Cardiac amyloidosis in patients undergoing aortic valve replacement for aortic stenosis

Back

ESC Premium Access

Cardiac amyloidosis in patients undergoing aortic valve replacement for aortic stenosis

Session: The 3I Role of Metabolic Imaging: Ischemia, Infection and Inflammation

Topic: Technology and Tracers

Speaker: Doctor S. Fukuzawa (Funabashi, JP)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Shigeru Fukuzawa

Funabashi Municipal Medical Center, Funabashi (Japan)

0 follower

6 more presentations in this session

The GLP-1 receptor agonist Semaglutide decreases vascular inflammation in a rabbit model of advanced atherosclerosis

Speaker: Doctor J. Kildevang Jensen (Gentofte, DK)

Access

Abstract

Slides

High-risk plaque burdens myocardial flow reserve in intermediate coronary artery disease: hybrid analysis of 13N-ammonia PET and coronary CT angiography.

Speaker: Doctor A. Yamamoto (Shinjyuku, JP)

Access

Abstract

Slides

Prognostic role of positron emission tomography in patients with known or suspected cardiac sarcoidosis. a systematic review and meta-analysis

Speaker: Doctor K. Bhatia (New York, US)

Access

Abstract

Slides

Splenic switch off as a novel marker for adenosine response in 13N-ammonia PET myocardial perfusion imaging - a pilot study.

Speaker: Doctor A. Bakula (Bern, CH)

Access

Abstract

Slides

Prediction for cardiac prognosis in patients with congestive heart failure by machine learning on dual-isotope myocardial semiconductor SPECT

Speaker: Doctor M. Shimizu (Yokohama, JP)

Access

Abstract

Slides

Access the full session

The 3I Role of Metabolic Imaging: Ischemia, Infection and Inflammation

Speakers: Doctor S. Fukuzawa, Doctor J. Kildevang Jensen, Doctor A. Yamamoto, Doctor K. Bhatia, Doctor A. Bakula...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources